Evidence map›Paper›PMID 41222851›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2026

Mapping of the EORTC QLQ-LC43 to EQ-5D-5 L index in patients with lung cancer: comparison of traditional regression models with machine learning technique.

Longlin Jiang, Yan Miao, Hong Zhou, Lin Peng, Yongtao Han, Xi Luo, Qiuling Shi, Xuefeng Leng, Qing Yang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Longlin JiangDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Yan MiaoDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Hong ZhouDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Lin PengDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Yongtao HanDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Xi LuoDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Qiuling ShiCenter for Cancer Prevention Research, Sichuan Cancer Center, School of Medicine, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.
Xuefeng LengDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.
Qing YangNursing department, Sichuan Clinical Research Center for Cancer. Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China. yangqingsc@163.com.ORCID http://orcid.org/0000-0002-9730-0901

Funding

Foundation of Department of Science and Technology of Sichuan Province 2020YFS0397Sichuan science and technology innovation seedling cultivation project 24PYXM0170
6 · The paper itself

Abstract

objectiveThe objective of this study was to create a mapping algorithm by utilizing traditional regression analyses and a machine learning approach to estimate EQ-5D-5 L values based on EORTC QLQ-LC43 data in the absence of direct EQ-5D-5 L measurements.

methodsData for EQ-5D-5 L and EORTC QLQ-LC43 were collected from patients with lung cancer at the Departments of Thoracic Surgery, Medical Oncology, and Radiation Oncology at Sichuan Cancer Hospital. Mapping algorithms were applied using the ordinary least squares model (OLS), Tobit model, Beta mixture regression (BM), the adjusted limited dependent variable mixture model (ALDVMM), and ridge regression (RR) as a machine learning model to map QLQ-LC43 results based on EQ-5D-5 L scores. To develop these models, dimension scores, squared items, and interaction items were incorporated. Performance metrics, including R², root mean square error (RMSE), and mean absolute error (MAE), were used to identify the optimal model. The stability of the models was assessed using five-fold cross-validation (CV).

resultsThe Beta mixture regression model (BETAMIX M1A), incorporating all dimensions of QLQ-C30 and QLQ-LC13 as covariates, exhibited the best mapping performance. The final prediction metrics were R²=0.816, RMSE = 0.125, MAE = 0.083, AIC=-717.810, and BIC=-482.609. The BM model has good explanatory ability and low prediction error. Five-fold cross-validation (CV) results also demonstrated that the BM model had the best mapping power.

conclusionsThis study developed an optimized mapping algorithm to predict the utility index from the QLQ-LC43 to the EQ-5D-5 L, offering an effective alternative for estimating EQ-5D-5 L values when preference-based health utility data are unavailable.

Indexed as

Lung NeoplasmsMachine LearningQuality of LifeAgedAlgorithmsChinaFemaleHumansMaleMiddle AgedRegression AnalysisSurveys and QuestionnairesEQ-5D-5LHealth-related quality of life (HRQoL)Lung cancerMachine learningMappingQLQ-LC43

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.